Application 213845
- Type
- ANDA
- Sponsor
- SUNSHINE LAKE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TENOFOVIR ALAFENAMIDE | TENOFOVIR ALAFENAMIDE | TABLET;ORAL | 25MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VEMLIDY | TENOFOVIR ALAFENAMIDE | Gilead Sciences, Inc. | 72e6b33c-0351-4070-9172-eeaa186c01d2 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | TENOFOVIR ALAFENAMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 68381 | ORIG | 2021-08-16 |